Market Tracker

08/29 10:03am ET

Alkermes Plc (NASDAQ:ALKS)

44.83
Data as of 9:48am ET
 +0.35 / +0.79%
Today’s Change
29.36
Today|||52-Week Range
54.25
+10.26%
Year-to-Date

Today’s Trading

Previous close44.48
Today’s open44.74
Day’s range44.39 - 44.83
Volume15,939
Average volume (3 months)730,786
Market cap$6.5B
Dividend yield--
Data as of 9:48am ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-79.81%
Earnings growth (next 5 years)+20.24%
Revenue growth (last year)+47.59%
P/E ratio373.6
Price/Sales5.42
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-0.30-0.24%
ICPTIntercept Pharmaceut...-0.95-0.33%
MDVNMedivation Inc+0.24+0.27%
TAROTaro Pharmaceutical ...-0.08-0.05%
Data as of 10:03am ET, 08/29/2014

Financials

Next reporting dateNovember 27, 2014
EPS forecast (this quarter)$0.02
Annual revenue (last year)$575.5M
Annual profit (last year)$25.0M
Net profit margin4.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts